4DMedical's Year-to-Date Fiscal 2026 Operating Revenue Rises 12% Year on Year
MT Newswires Live
Apr 30
4DMedical (ASX:4DX) said the operating revenue for year-to-date fiscal 2026 was AU$5 million, up 12% compared to the prior corresponding period, with gross margins exceeding 90%, according to a Thursday Australian bourse filing.
It reported operating revenue of AU$4.5 million in the prior-year period, according to a separate filing.
Receipts from customers in the fiscal third quarter ended March increased 18% year-over-year to AU$1.4 million, from AU$1.2 million.
Underlying software-as-a-service revenue was up 24% year-over-year for the nine months to March, driven by increased penetration across business-to-business software-as-a-service sites and distributors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.